Its a triple-agonist meaning it activates three receptors: GLP-1, GIP, and the glucagon receptor
So, does Zepbound cause constipation
pmc.ncbi.nlm.nih.gov Sonthalia S, Daulatabad D, Sarkar R
What oral weight loss medicines are currently available in the UK
[3] The SURMOUNT trials, which focused on weight management in individuals with and without diabetes, showed similar lipid improvements
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated (through intermediate steps of 5 mg, 7.5 mg, 10 mg, 12.5 mg) to a maintenance dose of 5 mg, 10 mg, or 15 mg based on individual response and tolerability